133.51
price down icon0.87%   -1.17
after-market Handel nachbörslich: 133.00 -0.51 -0.38%
loading
Schlusskurs vom Vortag:
$134.68
Offen:
$133.55
24-Stunden-Volumen:
514.97K
Relative Volume:
0.96
Marktkapitalisierung:
$6.66B
Einnahmen:
$338.46M
Nettoeinkommen (Verlust:
$-310.96M
KGV:
-20.45
EPS:
-6.53
Netto-Cashflow:
$-132.82M
1W Leistung:
+1.61%
1M Leistung:
+14.35%
6M Leistung:
+24.50%
1J Leistung:
+48.16%
1-Tages-Spanne:
Value
$132.61
$136.23
1-Wochen-Bereich:
Value
$126.80
$136.23
52-Wochen-Spanne:
Value
$75.56
$139.13

Axsome Therapeutics Inc Stock (AXSM) Company Profile

Name
Firmenname
Axsome Therapeutics Inc
Name
Telefon
(212) 332-3241
Name
Adresse
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Name
Mitarbeiter
589
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-18
Name
Neueste SEC-Einreichungen
Name
AXSM's Discussions on Twitter

Vergleichen Sie AXSM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AXSM
Axsome Therapeutics Inc
133.51 6.72B 338.46M -310.96M -132.82M -6.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.39 107.73B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
654.48 62.04B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
475.91 62.73B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
836.39 51.09B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.29 34.67B 398.11M -1.03B -868.57M -5.7032

Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-01 Eingeleitet B. Riley Securities Buy
2025-09-03 Fortgesetzt Wells Fargo Overweight
2025-07-03 Fortgesetzt Morgan Stanley Overweight
2025-06-03 Eingeleitet Oppenheimer Outperform
2025-04-07 Eingeleitet Jefferies Buy
2025-02-11 Eingeleitet Deutsche Bank Buy
2024-12-31 Bestätigt Mizuho Outperform
2024-09-03 Eingeleitet Wells Fargo Overweight
2024-08-06 Hochstufung BofA Securities Neutral → Buy
2024-07-22 Eingeleitet Needham Buy
2024-04-29 Hochstufung Morgan Stanley Equal-Weight → Overweight
2024-03-19 Eingeleitet Robert W. Baird Outperform
2024-02-06 Eingeleitet UBS Buy
2024-01-25 Eingeleitet RBC Capital Mkts Outperform
2023-12-13 Eingeleitet Citigroup Buy
2023-08-08 Hochstufung BofA Securities Underperform → Neutral
2023-01-05 Eingeleitet Piper Sandler Neutral
2022-11-01 Eingeleitet Loop Capital Buy
2022-09-07 Fortgesetzt Mizuho Buy
2021-08-10 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-06-10 Eingeleitet Berenberg Buy
2021-01-08 Eingeleitet Jefferies Buy
2020-12-16 Eingeleitet Mizuho Buy
2020-09-29 Eingeleitet BofA Securities Underperform
2020-09-10 Eingeleitet Morgan Stanley Overweight
2020-04-28 Bestätigt H.C. Wainwright Buy
2020-04-14 Eingeleitet Cowen Outperform
2019-12-30 Bestätigt H.C. Wainwright Buy
2019-12-17 Bestätigt H.C. Wainwright Buy
2019-12-16 Bestätigt Guggenheim Buy
2019-10-16 Eingeleitet Guggenheim Buy
2019-09-18 Eingeleitet William Blair Outperform
2019-05-28 Eingeleitet SunTrust Buy
2019-05-23 Bestätigt H.C. Wainwright Buy
2019-04-08 Eingeleitet SVB Leerink Outperform
2019-03-15 Bestätigt H.C. Wainwright Buy
2016-10-03 Fortgesetzt Brean Capital Buy
2015-12-15 Eingeleitet Cantor Fitzgerald Buy
2015-12-14 Eingeleitet Ladenburg Thalmann Buy
Alle ansehen

Axsome Therapeutics Inc Aktie (AXSM) Neueste Nachrichten

pulisher
08:13 AM

How rising interest rates impact Axsome Therapeutics Inc. stockEarnings Miss & Technical Entry and Exit Alerts - newser.com

08:13 AM
pulisher
08:01 AM

Historical volatility pattern of Axsome Therapeutics Inc. visualized2025 Valuation Update & Real-Time Stock Movement Alerts - newser.com

08:01 AM
pulisher
07:30 AM

Can machine learning forecast Axsome Therapeutics Inc. recoveryEarnings Risk Summary & Smart Investment Allocation Insights - newser.com

07:30 AM
pulisher
06:33 AM

Market reaction to Axsome Therapeutics Inc.’s recent news2025 Bull vs Bear & Smart Money Movement Tracker - newser.com

06:33 AM
pulisher
05:47 AM

Peregrine Capital Management LLC Acquires 13,747 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat

05:47 AM
pulisher
05:16 AM

Axsome Therapeutics Inc. stock trend forecastInsider Selling & Stock Portfolio Risk Management - newser.com

05:16 AM
pulisher
04:48 AM

How Axsome Therapeutics Inc. stock performs in rate cut cyclesWeekly Investment Summary & Expert Approved Trade Ideas - newser.com

04:48 AM
pulisher
03:54 AM

Has Axsome Therapeutics Inc. formed a bullish divergenceMarket Sentiment Report & Short-Term High Return Strategies - newser.com

03:54 AM
pulisher
03:49 AM

Can Axsome Therapeutics Inc. stock continue upward trendJuly 2025 Setups & Technical Pattern Based Buy Signals - newser.com

03:49 AM
pulisher
03:29 AM

Allianz Asset Management GmbH Increases Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat

03:29 AM
pulisher
02:57 AM

Axsome Therapeutics Inc. stock volume spike explainedJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com

02:57 AM
pulisher
02:52 AM

How Axsome Therapeutics Inc. stock compares to market leaders2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com

02:52 AM
pulisher
02:52 AM

Is Axsome Therapeutics Inc. stock attractive after correctionWeekly Market Outlook & Weekly High Return Stock Opportunities - newser.com

02:52 AM
pulisher
02:51 AM

Is Axsome Therapeutics Inc. stock a buy on dipsJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com

02:51 AM
pulisher
01:52 AM

How supply chain issues affect Axsome Therapeutics Inc. stock2025 Winners & Losers & Weekly Stock Performance Updates - Fundação Cultural do Pará

01:52 AM
pulisher
01:25 AM

How Axsome Therapeutics Inc. (19X) stock reacts to Fed tightening2025 Top Gainers & Smart Allocation Stock Tips - newser.com

01:25 AM
pulisher
12:50 PM

Bull Bear: Is Axsome Therapeutics Inc. stock a top pick in earnings seasonQuarterly Growth Report & Fast Moving Trade Plans - Fundação Cultural do Pará

12:50 PM
pulisher
12:36 PM

Tools to assess Axsome Therapeutics Inc.’s risk profile2025 Winners & Losers & Risk Managed Investment Strategies - newser.com

12:36 PM
pulisher
Oct 27, 2025

Is a relief rally coming for Axsome Therapeutics Inc. holdersCPI Data & Low Volatility Stock Recommendations - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is Axsome Therapeutics Inc. stock gaining market sharePortfolio Risk Summary & Reliable Price Action Trade Plans - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What Wall Street predicts for Axsome Therapeutics Inc. stock priceTrade Performance Summary & Low Volatility Stock Suggestions - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Axsome Therapeutics Advances Study on Solriamfetol for Binge Eating Disorder - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Axsome Therapeutics’ AXS-05 Study: A Potential Game-Changer for MDD Relapse Prevention - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Axsome Therapeutics (AXSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - sharewise.com

Oct 27, 2025
pulisher
Oct 27, 2025

What candlestick patterns are forming on Axsome Therapeutics Inc.Earnings Summary Report & Stepwise Trade Signal Implementation - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is Axsome Therapeutics Inc. forming a reversal patternGold Moves & Low Risk High Reward Ideas - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Axsome Therapeutics (AXSM) Projected to Post Earnings on Monday - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

Surprises Report: How rising interest rates impact Axsome Therapeutics Inc. stockJuly 2025 Recap & Fast Moving Market Watchlists - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Published on: 2025-10-27 05:40:44 - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

2,100 Shares in Axsome Therapeutics, Inc. $AXSM Bought by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat

Oct 27, 2025

Finanzdaten der Axsome Therapeutics Inc-Aktie (AXSM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$36.41
price down icon 2.28%
$91.65
price down icon 1.54%
$29.13
price up icon 0.34%
$105.03
price down icon 0.96%
biotechnology ONC
$316.85
price up icon 0.45%
$165.29
price up icon 0.77%
Kapitalisierung:     |  Volumen (24h):